SPECIAL COVERAGE — Biologics
CDMO World > China, Pharmaceuticals > NEWS CAPSULES: China CDMO Pharmaceutical Manufacturing – August 2025

NEWS CAPSULES: China CDMO Pharmaceutical Manufacturing – August 2025

China’s CDMO pharmaceutical manufacturing landscape continues to grow with equity fundraising and advanced facility development in small molecules and fermentation.

NEWS CAPSULES China CDMO Pharmaceutical Manufacturing

August 4, 2025

The Chinese pharmaceutical CDMO sector continues sustaining momentum in small molecule API development and site expansion, underpinned by strategic insights and facility launches. These China CDMO pharmaceutical manufacturing capsules for August 2025 outline Flamma’s new Dalian plant, the latest industry report from Frost & Sullivan, and market growth markers.

Capsule 1: Flamma Launches cGMP API CDMO Plant in Dalian

Flamma opened a new cGMP-compatible facility in Dalian to enhance its manufacturing and commercialization capacity for small molecule APIs aimed at innovator clients worldwide.

Capsule 2: Frost & Sullivan Releases “2025 China Pharmaceutical CDMO Blue Book”

The Blue Book provides extensive analysis of China’s CDMO evolution—highlighting dual-engine expansion across small molecule, peptide, ADC, and CGT CDMO segments, along with growth drivers and representative firms like Porton Pharma and Pharmaron.

Capsule 3: China Small Molecule CDMO Market Forecast to Surge to $46B

Industry research projects the China small molecule CDMO market will reach $46 billion by 2030, growing at a CAGR of 19.4%. This expansion is linked to cost advantages, growing API outsourcing, and strong demand in oncology and generics.

Internal Link: Explore additional China CDMO insights at CDMOworld.com

Image placeholder

Lorem ipsum amet elit morbi dolor tortor. Vivamus eget mollis nostra ullam corper. Pharetra torquent auctor metus felis nibh velit. Natoque tellus semper taciti nostra. Semper pharetra montes habitant congue integer magnis.

User avatar placeholder
Written by CDMO

NEWS CAPSULES: India CDMO Biologics Expansion & Market Moves

NEWS CAPSULES: Europe CDMO Pharmaceutical Manufacturing – August 2025

Categories

Latest Articles

Subscribe to Newsletter

The Latest 

		[{"id":55295,"link":"https:\/\/cdmoworld.com\/single-use-systems-extractables-leachables-strategy-cdmo\/","name":"single-use-systems-extractables-leachables-strategy-cdmo","thumbnail":{"url":"https:\/\/cdmoworld.com\/wp-content\/uploads\/2026\/03\/Untitled-design-81.png","alt":"A group of scientists in lab coats and protective gear working together in a modern lab, performing research with test tubes, a microscope, and pipettes."},"title":"Single-Use Systems in Biologics Manufacturing: Extractables\/Leachables Strategy for CDMO","postMeta":[],"author":{"name":"CDMO World","link":"https:\/\/cdmoworld.com\/author\/raismrafiq\/"},"date":"Mar 6, 2026","dateGMT":"2026-03-06 12:24:58","modifiedDate":"2026-03-06 12:24:58","modifiedDateGMT":"2026-03-06 12:24:58","commentCount":"0","commentStatus":"closed","categories":{"coma":"<a href=\"https:\/\/cdmoworld.com\/category\/qa\/\" rel=\"category tag\">Q&A<\/a>","space":"<a href=\"https:\/\/cdmoworld.com\/category\/qa\/\" rel=\"category tag\">Q&A<\/a>"},"taxonomies":{"post_tag":"<a href='https:\/\/cdmoworld.com\/tag\/biologics-manufacturing\/' rel='post_tag'>Biologics Manufacturing<\/a><a href='https:\/\/cdmoworld.com\/tag\/cdmo\/' rel='post_tag'>CDMO<\/a><a href='https:\/\/cdmoworld.com\/tag\/cgmp-compliance\/' rel='post_tag'>cGMP Compliance<\/a><a href='https:\/\/cdmoworld.com\/tag\/regulatory-compliance\/' rel='post_tag'>Regulatory Compliance<\/a><a href='https:\/\/cdmoworld.com\/tag\/tech-transfer\/' rel='post_tag'>Tech Transfer<\/a><a href='https:\/\/cdmoworld.com\/tag\/testing\/' rel='post_tag'>Testing<\/a>","content-type":"<a href='https:\/\/cdmoworld.com\/content-type\/articles\/' rel='content-type'>Articles<\/a>"},"readTime":{"min":8,"sec":12},"status":"publish","excerpt":"Transitioning to Single-Use Systems (SUS) offers speed but introduces chemical risks. This 2,500-word Q&A-style guide provides a comprehensive Extractables and Leachables Strategy for sponsors working with CDMOs. Discover expert tips on risk assessment, USP compliance, and analytical validation to ensure patient safety in biologics manufacturing."},{"id":55294,"link":"https:\/\/cdmoworld.com\/drug-substance-vs-drug-product-comparability-cdmo\/","name":"drug-substance-vs-drug-product-comparability-cdmo","thumbnail":{"url":"https:\/\/cdmoworld.com\/wp-content\/uploads\/2026\/03\/Untitled-design-80.png","alt":"A digital illustration contrasting drug substance and drug product, with vials of blue liquid on the left representing drug substance, and vials with capsules and tablets on the right representing drug products, all set in a futuristic lab environment."},"title":"Drug Substance vs Drug Product Comparability: How CDMO Changes Expand Your Study Scope","postMeta":[],"author":{"name":"CDMO World","link":"https:\/\/cdmoworld.com\/author\/raismrafiq\/"},"date":"Mar 6, 2026","dateGMT":"2026-03-06 12:09:04","modifiedDate":"2026-03-06 12:09:18","modifiedDateGMT":"2026-03-06 12:09:18","commentCount":"0","commentStatus":"closed","categories":{"coma":"<a href=\"https:\/\/cdmoworld.com\/category\/tips\/\" rel=\"category tag\">Tips<\/a>","space":"<a href=\"https:\/\/cdmoworld.com\/category\/tips\/\" rel=\"category tag\">Tips<\/a>"},"taxonomies":{"post_tag":"<a href='https:\/\/cdmoworld.com\/tag\/biologics-manufacturing\/' rel='post_tag'>Biologics Manufacturing<\/a><a href='https:\/\/cdmoworld.com\/tag\/cdmo\/' rel='post_tag'>CDMO<\/a><a href='https:\/\/cdmoworld.com\/tag\/cgmp-compliance\/' rel='post_tag'>cGMP Compliance<\/a><a href='https:\/\/cdmoworld.com\/tag\/regulatory-compliance\/' rel='post_tag'>Regulatory Compliance<\/a><a href='https:\/\/cdmoworld.com\/tag\/tech-transfer\/' rel='post_tag'>Tech Transfer<\/a><a href='https:\/\/cdmoworld.com\/tag\/testing\/' rel='post_tag'>Testing<\/a>","content-type":"<a href='https:\/\/cdmoworld.com\/content-type\/articles\/' rel='content-type'>Articles<\/a>"},"readTime":{"min":7,"sec":11},"status":"publish","excerpt":"Navigating the nuances of Drug Substance vs Drug Product Comparability is vital when switching CDMOs. This 2,500-word guide provides expert tips on expanding your study scope. Learn how manufacturing changes impact analytical bridging and how to build a regulatory-compliant comparability plan that ensures safety for biologics."},{"id":55290,"link":"https:\/\/cdmoworld.com\/plasmid-dna-tech-transfer-cdmo-guide\/","name":"plasmid-dna-tech-transfer-cdmo-guide","thumbnail":{"url":"https:\/\/cdmoworld.com\/wp-content\/uploads\/2026\/03\/Untitled-design-79.png","alt":"A hand holding tweezers is shown cutting DNA strands, symbolizing genetic engineering and plasmid DNA technology transfer in a lab setting."},"title":"Plasmid DNA Tech Transfer to a CDMO: Process, Controls, and Release Testing","postMeta":[],"author":{"name":"CDMO World","link":"https:\/\/cdmoworld.com\/author\/raismrafiq\/"},"date":"Mar 6, 2026","dateGMT":"2026-03-06 11:49:25","modifiedDate":"2026-03-06 11:49:25","modifiedDateGMT":"2026-03-06 11:49:25","commentCount":"0","commentStatus":"closed","categories":{"coma":"<a href=\"https:\/\/cdmoworld.com\/category\/sectors\/technology-transfer\/\" rel=\"category tag\">Technology Transfer<\/a>","space":"<a href=\"https:\/\/cdmoworld.com\/category\/sectors\/technology-transfer\/\" rel=\"category tag\">Technology Transfer<\/a>"},"taxonomies":{"post_tag":"<a href='https:\/\/cdmoworld.com\/tag\/biologics-manufacturing\/' rel='post_tag'>Biologics Manufacturing<\/a><a href='https:\/\/cdmoworld.com\/tag\/bioprocess-development\/' rel='post_tag'>Bioprocess Development<\/a><a href='https:\/\/cdmoworld.com\/tag\/cdmo\/' rel='post_tag'>CDMO<\/a><a href='https:\/\/cdmoworld.com\/tag\/cgmp-compliance\/' rel='post_tag'>cGMP Compliance<\/a><a href='https:\/\/cdmoworld.com\/tag\/regulatory-compliance\/' rel='post_tag'>Regulatory Compliance<\/a><a href='https:\/\/cdmoworld.com\/tag\/tech-transfer\/' rel='post_tag'>Tech Transfer<\/a>","content-type":"<a href='https:\/\/cdmoworld.com\/content-type\/articles\/' rel='content-type'>Articles<\/a>"},"readTime":{"min":8,"sec":36},"status":"publish","excerpt":"Plasmid DNA is the backbone of modern gene therapy and mRNA vaccine production. This 2,500-word technical guide explores the complexities of Plasmid DNA Tech Transfer to a CDMO. We analyze critical process parameters, analytical validation, and release testing requirements to ensure your scale-up meets global regulatory standards."},{"id":55285,"link":"https:\/\/cdmoworld.com\/adventitious-agent-testing-biologics-cdmo-strategy\/","name":"adventitious-agent-testing-biologics-cdmo-strategy","thumbnail":{"url":"https:\/\/cdmoworld.com\/wp-content\/uploads\/2026\/03\/Untitled-design-78.png","alt":"A researcher holding a test tube while examining cancerous cells under a microscope, illustrating biological research and testing in a lab environment."},"title":"Adventitious Agent Testing in Biologics: Building a CDMO Testing Strategy That Regulators Accept","postMeta":[],"author":{"name":"CDMO World","link":"https:\/\/cdmoworld.com\/author\/raismrafiq\/"},"date":"Mar 6, 2026","dateGMT":"2026-03-06 11:32:43","modifiedDate":"2026-03-06 12:11:12","modifiedDateGMT":"2026-03-06 12:11:12","commentCount":"0","commentStatus":"closed","categories":{"coma":"<a href=\"https:\/\/cdmoworld.com\/category\/sectors\/quality-control\/\" rel=\"category tag\">Quality Control<\/a>","space":"<a href=\"https:\/\/cdmoworld.com\/category\/sectors\/quality-control\/\" rel=\"category tag\">Quality Control<\/a>"},"taxonomies":{"post_tag":"<a href='https:\/\/cdmoworld.com\/tag\/adventitious-agent-testing\/' rel='post_tag'>Adventitious Agent Testing<\/a><a href='https:\/\/cdmoworld.com\/tag\/biologics-manufacturing\/' rel='post_tag'>Biologics Manufacturing<\/a><a href='https:\/\/cdmoworld.com\/tag\/cdmo\/' rel='post_tag'>CDMO<\/a><a href='https:\/\/cdmoworld.com\/tag\/cgmp-compliance\/' rel='post_tag'>cGMP Compliance<\/a><a href='https:\/\/cdmoworld.com\/tag\/quality-control\/' rel='post_tag'>Quality Control<\/a><a href='https:\/\/cdmoworld.com\/tag\/regulatory-compliance\/' rel='post_tag'>Regulatory Compliance<\/a>","content-type":"<a href='https:\/\/cdmoworld.com\/content-type\/articles\/' rel='content-type'>Articles<\/a>"},"readTime":{"min":8,"sec":3},"status":"publish","excerpt":"Protecting biologics from viral, bacterial, and fungal contaminants is a regulatory mandate. This 2,500-word guide details Adventitious Agent Testing strategies at CDMOs. Explore in vitro and in vivo assays, Next-Generation Sequencing (NGS) trends, and how to structure your testing program to ensure safety and clinical success."},{"id":55283,"link":"https:\/\/cdmoworld.com\/rapid-mycoplasma-methods-biologics-qc-validation\/","name":"rapid-mycoplasma-methods-biologics-qc-validation","thumbnail":{"url":"https:\/\/cdmoworld.com\/wp-content\/uploads\/2026\/03\/Untitled-design-77.png","alt":"A lab technician in blue gloves adds a droplet to a Petri dish containing glowing mycoplasma colonies, while test tubes are prepared in the background in a modern laboratory setup."},"title":"Rapid Mycoplasma Methods in Biologics QC: When CDMOs Can Use Them and How to Validate","postMeta":[],"author":{"name":"CDMO World","link":"https:\/\/cdmoworld.com\/author\/raismrafiq\/"},"date":"Mar 6, 2026","dateGMT":"2026-03-06 11:12:20","modifiedDate":"2026-03-06 11:12:21","modifiedDateGMT":"2026-03-06 11:12:21","commentCount":"0","commentStatus":"closed","categories":{"coma":"<a href=\"https:\/\/cdmoworld.com\/category\/features\/columns\/testing-matters\/\" rel=\"category tag\">Testing Matters<\/a>","space":"<a href=\"https:\/\/cdmoworld.com\/category\/features\/columns\/testing-matters\/\" rel=\"category tag\">Testing Matters<\/a>"},"taxonomies":{"post_tag":"<a href='https:\/\/cdmoworld.com\/tag\/biologics-manufacturing\/' rel='post_tag'>Biologics Manufacturing<\/a><a href='https:\/\/cdmoworld.com\/tag\/cdmo\/' rel='post_tag'>CDMO<\/a><a href='https:\/\/cdmoworld.com\/tag\/cgmp-compliance\/' rel='post_tag'>cGMP Compliance<\/a><a href='https:\/\/cdmoworld.com\/tag\/quality-control\/' rel='post_tag'>Quality Control<\/a><a href='https:\/\/cdmoworld.com\/tag\/regulatory-compliance\/' rel='post_tag'>Regulatory Compliance<\/a><a href='https:\/\/cdmoworld.com\/tag\/testing\/' rel='post_tag'>Testing<\/a>","content-type":"<a href='https:\/\/cdmoworld.com\/content-type\/articles\/' rel='content-type'>Articles<\/a>"},"readTime":{"min":7,"sec":52},"status":"publish","excerpt":"Traditional mycoplasma testing takes 28 days, delaying critical patient therapies. This 2,500-word guide explores Rapid Mycoplasma Methods, detailing when CDMOs can implement them and the rigorous validation steps required to satisfy global regulators. Learn how to accelerate your biologics QC without compromising safety or compliance."}]
Sponsor or AdvertiseMedia Kit
Latest Tips
Latest Q&A
CDMWorld Footer